IMMUNOCOMPETENCE OF PATIENTS WITH BRONCHOGENIC CARCINOMA

[1] AMERY W, 1975, 9TH P INT C CHEM LON, P1

[2] BAHN AK, 1972, BASIC MEDICAL STATIS

[3] BENTWICH Z, 1973, CLIN IMMUNOL IMMUNOP, V1, P511, DOI 10.1016/0090-1229(73)90007-X

[4] CATALONA WJ, 1973, CANCER, V31, P353, DOI 10.1002/1097-0142(197302)31:2<353::AID-CNCR2820310213>3.0.CO

[5] 2-B

[6] CATALONA WJ, 1973, CANCER, V31, P65, DOI 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO

[7] 2-Y

[8] CHRETIEN PB, 1973, SURG GYNECOL OBSTET, V136, P380

[9] CONCANNON JP, 1975, 17TH P ANN M AM SOC, P33

[10] COTTIER H, 1974, INTERACTION RAD HOST, P30

[1] AMERY W, 1975, 9TH P INT C CHEM LON, P1

[2] BAHN AK, 1972, BASIC MEDICAL STATIS

[3] BENTWICH Z, 1973, CLIN IMMUNOL IMMUNOP, V1, P511, DOI 10.1016/0090-1229(73)90007-X

[4] CATALONA WJ, 1973, CANCER, V31, P353, DOI 10.1002/1097-0142(197302)31:2<353::AID-CNCR2820310213>3.0.CO

[5] 2-B

[6] CATALONA WJ, 1973, CANCER, V31, P65, DOI 10.1002/1097-0142(197301)31:1<65::AID-CNCR2820310109>3.0.CO

[7] 2-Y

[8] CHRETIEN PB, 1973, SURG GYNECOL OBSTET, V136, P380

[9] CONCANNON JP, 1975, 17TH P ANN M AM SOC, P33

[10] COTTIER H, 1974, INTERACTION RAD HOST, P30